BRCA基因表达在胶质瘤中的预后预测价值:一项遗传生存分析研究
该研究基于癌症基因组图谱(TCGA)的低级别胶质瘤(LGG)和胶质母细胞瘤(GBM)队列,采用Kaplan-Meier和log-rank分析BRCA1与BRCA2表达与生存的关系。结果显示BRCA1和BRCA2高表达与LGG患者生存率降低显著相关(P=0.00),在GBM中表达越高生存率也越低但相关性不显著(P<0.01)。结论提示BRCA1和BRCA2可作为胶质瘤的不良预后因素,在LGG中意义更大。
要点
- BRCA1和BRCA2高表达与LGG患者生存率降低显著相关(P=0.00)。
- GBM中BRCA表达越高生存率越低,但相关性不显著(P<0.01)。
- BRCA1和BRCA2可视为胶质瘤不良预后因素,在LGG中意义更大。
核心结论
- BRCA1和BRCA2可被视为胶质瘤患者的不良预后因素,在低级别胶质瘤患者中意义更大。
研究设计与样本
- 研究分析癌症基因组图谱(TCGA)中的低级别胶质瘤(LGG)和胶质母细胞瘤(GBM)队列。
- 采用Kaplan-Meier和log-rank分析确定BRCA1和BRCA2表达与生存的关系。
主要发现
- BRCA1和BRCA2表达与LGG患者生存的相关性显著(P=0.00和P=0.00)。
- 在LGG和GBM队列中,表达水平越高生存率越低,但GBM患者中相关性不显著(P<0.01)。
关键数值与推荐
- LGG中BRCA1表达与生存相关P=0.00,BRCA2表达与生存相关P=0.00。
- GBM中BRCA表达与生存相关性不显著,P<0.01。
临床怎么用
- BRCA1和BRCA2表达水平可用于胶质瘤预后评估,尤其在低级别胶质瘤中提示不良预后。
- 未来需更深入实验阐明胶质瘤发生机制并确定潜在基因治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gliomas are the most common type of central nervous system tumor in adults, and they have an extremely poor prognosis. Gliomas are classified into 4 grades, with low-grade gliomas (LGGs) constituting grades I and II and glioblastoma multiforme (GBM) constituting grade IV. Breast cancer susceptibility genes BRCA1 and BRCA2 play a role in DNA repair and are required for genome stability. METHODS: We analyzed the LGG and GBM cohorts from The Cancer Genome Atlas. We used Kaplan-Meier and log-rank analysis to determine the relationship between BRCA1 and BRCA2 expression and survival. RESULTS: Correlation of BRCA1 and BRCA2 expression with survival in patients with LGG was significant (P = 0.00 and P = 0.00). The higher the levels of expression were, the lower survival rates were in both LGG and GBM cohorts, but the correlation was not significant in patients with GBM (P < 0.01). CONCLUSIONS: Our findings suggest that BRCA1 and BRCA2 can be regarded as poor prognostic factors in patients with glioma, with greater significance in patients with LGG. In the future, more in-depth experiments will enable us to elucidate the mechanism of gliomagenesis and identify potential gene therapy targets.
引用
- Meimand SE, Pour-Rashidi A, Shahrbabak MM, et al. The Prognostication Potential of BRCA Genes Expression in Gliomas: A Genetic Survival Analysis Study. World Neurosurg. 2021. PMID: 34607064. doi:10.1016/j.wneu.2021.09.107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。